|Bid||109.45 x 900|
|Ask||109.91 x 1200|
|Day's Range||108.72 - 115.20|
|52 Week Range||108.71 - 174.79|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Yahoo Finance’s Brian Sozzi and Julie Hyman speak with Christiana Bardon, BioImpact Capital Co-Managing Partner, about MPM Capital’s second Oncology Impact Fund, and outlook for the biotech space.
Building a core satellite ETF portfolio can give investors the best of two worlds.
ETFs that look at a subsector of biotech have significantly outperformed broader biotech funds this year.